title: Acceptability of human papillomavirus vaccine: a survey among master of business administration students in KwaZulu-Natal, South Africa.
abstract: Cervical cancer is a preventable public health problem. The two new human papillomavirus (HPV) vaccines are available but not accessible to everyone in South Africa, as they are very expensive. This study aimed to investigate educated peoples acceptability regarding HPV vaccination. This was a cross-sectional survey conducted among 146 master of business administration students by self-administered, anonymous questionnaire. The majority (74%) of the participants ever heard of cervical cancer, but only 26.2% heard about HPV. After reading the fact information regarding cervical cancer and HPV, the intention to vaccinate their daughters increased from 88% to 97.2% (P = 0.003). The majority (75.4%) indicated that HPV vaccination should be given before their daughters are mature enough to understand about sex, and 80.3% reported that they will discuss matters related to sex with their daughters if their daughters want to know about the vaccine. Those who did not want to vaccinate their daughters highlighted that they want more information regarding safety of the vaccine which might change their decision towards HPV vaccination. A health education information method can increase the vaccination acceptance rate in South Africa.
authors.affiliation: Graduate School of Business and Leadership, University of KwaZulu-Natal, Durban 4000, South Africa.
authors.forename: Muhammad Ehsanul
authors.initials: ME
authors.lastname: Hoque
authors.affiliation: Medical Sociology and Health Policy, University of Antwerp, Antwerp 2610, Belgium.
authors.forename: Guido
authors.identifier: 0000-0002-4611-4076
authors.initials: G
authors.lastname: Van Hal
mesh_terms: D000293:Adolescent; D000328:Adult; D003132:Commerce; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D010342:Patient Acceptance of Health Care; D013019:South Africa; D013334:Students; D011795:Surveys and Questionnaires; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D014611:Vaccination; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines